Candel Therapeutics
CADL
CADL
25 hedge funds and large institutions have $19.1M invested in Candel Therapeutics in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1.07% less ownership
Funds ownership: 22.12% → 21.05% (-1.1%)
7% less capital invested
Capital invested by funds: $20.6M → $19.1M (-$1.46M)
Holders
25
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$182K | |
| 2 | +$57.1K | |
| 3 | +$50.3K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.89K |
| 5 |
Morgan Stanley
New York
|
+$2.23K |
Top Sellers
| 1 | -$1.15M | |
| 2 | -$33K | |
| 3 | -$14.9K | |
| 4 |
PHK
Point72 Hong Kong
Hong Kong
|
-$2K |
| 5 |
Citigroup
New York
|
-$322 |